Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19826050

Cancer Res. 2009 Oct 15 69 20 8058-66

Download in:

View as

General Info

PMID
19826050